Early intervention combined with targeted treatment promotes cognitive and behavioral improvements in young children with fragile x syndrome
- PMID: 23074686
- PMCID: PMC3447258
- DOI: 10.1155/2012/280813
Early intervention combined with targeted treatment promotes cognitive and behavioral improvements in young children with fragile x syndrome
Abstract
Fragile X syndrome (FXS) is the most common inherited cause of intellectual disability due to an expansion in the full mutation range (>200 CGG repeats) of the promoter region of the FMR1 gene leading to gene silencing. Lack of FMRP, a critical protein for dendritic spine formation and maturation, will cause FXS. Early environmental enrichment combined with pharmacological intervention has been proven to rescue dendritic spine abnormalities in the animal model of FXS. Here we report on 2 young children with FXS who were treated early with a combination of targeted treatment and intensive educational interventions leading to improvement in their cognition and behavior and a normal IQ.
Similar articles
-
Epigenetic characterization of the FMR1 gene and aberrant neurodevelopment in human induced pluripotent stem cell models of fragile X syndrome.PLoS One. 2011;6(10):e26203. doi: 10.1371/journal.pone.0026203. Epub 2011 Oct 12. PLoS One. 2011. PMID: 22022567 Free PMC article.
-
ICAM5 as a Novel Target for Treating Cognitive Impairment in Fragile X Syndrome.J Neurosci. 2020 Feb 5;40(6):1355-1365. doi: 10.1523/JNEUROSCI.2626-18.2019. Epub 2019 Dec 27. J Neurosci. 2020. PMID: 31882402 Free PMC article.
-
Modeling fragile X syndrome in the Fmr1 knockout mouse.Intractable Rare Dis Res. 2014 Nov;3(4):118-33. doi: 10.5582/irdr.2014.01024. Intractable Rare Dis Res. 2014. PMID: 25606362 Free PMC article. Review.
-
Fragile X syndrome: A review of clinical management.Intractable Rare Dis Res. 2016 Aug;5(3):145-57. doi: 10.5582/irdr.2016.01048. Intractable Rare Dis Res. 2016. PMID: 27672537 Free PMC article. Review.
-
CGG-repeat dynamics and FMR1 gene silencing in fragile X syndrome stem cells and stem cell-derived neurons.Mol Autism. 2016 Oct 6;7:42. doi: 10.1186/s13229-016-0105-9. eCollection 2016. Mol Autism. 2016. PMID: 27713816 Free PMC article.
Cited by
-
The impact of social-environmental factors on IQ in syndromic intellectual developmental disabilities.J Clin Transl Sci. 2024 Apr 5;8(1):e59. doi: 10.1017/cts.2024.510. eCollection 2024. J Clin Transl Sci. 2024. PMID: 38655457 Free PMC article. Review.
-
Astrocytes in fragile X syndrome.Front Cell Neurosci. 2024 Jan 8;17:1322541. doi: 10.3389/fncel.2023.1322541. eCollection 2023. Front Cell Neurosci. 2024. PMID: 38259499 Free PMC article. Review.
-
Parental Preferences for Expanded Newborn Screening: What Are the Limits?Children (Basel). 2023 Aug 9;10(8):1362. doi: 10.3390/children10081362. Children (Basel). 2023. PMID: 37628361 Free PMC article.
-
Early 7,8-Dihydroxyflavone Administration Ameliorates Synaptic and Behavioral Deficits in the Young FXS Animal Model by Acting on BDNF-TrkB Pathway.Mol Neurobiol. 2023 May;60(5):2539-2552. doi: 10.1007/s12035-023-03226-w. Epub 2023 Jan 21. Mol Neurobiol. 2023. PMID: 36680734
-
Behavioral Problems in Fragile X Syndrome: A Review of Clinical Management.Cureus. 2022 Feb 2;14(2):e21840. doi: 10.7759/cureus.21840. eCollection 2022 Feb. Cureus. 2022. PMID: 35291526 Free PMC article. Review.
References
-
- Irwin SA, Galvez R, Greenough WT. Dendritic spine structural anomalies in fragile-X mental retardation syndrome. Cerebral Cortex. 2000;10(10):1038–1044. - PubMed
-
- Loesch DZ, Huggins RM, Hagerman RJ. Phenotypic variation and FMRP levels in fragile X. Mental Retardation and Developmental Disabilities Research Reviews. 2004;10(1):31–41. - PubMed
Publication types
Grants and funding
LinkOut - more resources
Full Text Sources